等待开盘 05-18 09:30:00 美东时间
-0.360
-1.69%
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
Health officials explored restricting specific antidepressants among SSRI drugs-sourcesKennedy announced other steps to reduce use of the medicines on MondayKennedy says SSRIs are overprescribed and, without evidence,
05-09 00:02
Piper Sandler analyst David Amsellem maintains Definium Therapeutics (NASDAQ:DFTX) with a Overweight and lowers the price target from $49 to $48.
05-08 23:05
Definium Therapeutics (NASDAQ:DFTX) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.48) by 47.92 percent. This is a 102.86 percent decrease over losses of $(0.35) per
05-08 04:09
This whale alert can help traders discover the next big trading opportunities. ...
04-25 01:35
Definium Therapeutics stock rises after hours amid psychedelic sector rally following Trump's regulatory push.
04-21 15:44
Psychedelic drug maker shares jumped in Monday pre-market after an order from President Donald Trump to speed up psychedelic drug reviews
04-20 20:35
今日重点评级关注:Guggenheim:维持AtaiBeckley Inc."买入"评级,目标价从11美元升至16美元;RBC Capital:维持MeiraGTx Holdings"跑赢大市"评级,目标价从16美元升至24美元
04-20 11:33
Stifel starts Definium coverage, citing strong DT120 potential in anxiety and key 2026 trial catalysts shaping outlook.
04-18 02:06
今日重点评级关注:HC Wainwright & Co.:维持FibroBiologics"买入"评级,目标价从4美元升至8美元;摩根士丹利:维持Ultragenyx药业"超配"评级,目标价从50美元升至67美元
04-17 11:27